ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.6603
-0.0097 (-1.45%)
At close: Jul 7, 2025, 4:00 PM
0.6600
-0.0003 (-0.05%)
After-hours: Jul 7, 2025, 7:39 PM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $3.22 million as of July 7, 2025. Its market cap has decreased by -26.58% in one year.
Market Cap
3.22M
Enterprise Value
1.63M
1-Year Change
-26.58%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $3.22M, a decrease of -96.63%. That is a compound annual growth rate of -63.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 3.27M | 22.81% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |